Download PDF
Horm Metab Res 2009; 41(9): 676-679
DOI: 10.1055/s-0029-1224133
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

The Value of Immunoassays for Metanephrines in the Biochemical Diagnosis of Pheochromocytomas

N. Unger 1 , T. Deutschbein 1 , M. K. Walz 2 , K. Mann 1 , S. Petersenn 1
  • 1Department of Endocrinology and Division of Laboratory Research, Medical Center, University of Duisburg-Essen, Essen, Germany
  • 2Department of Surgery and Center of Minimally Invasive Surgery, Kliniken Essen-Mitte, Essen, Germany
Further Information

Publication History

received 18.12.2008

accepted 24.04.2009

Publication Date:
25 June 2009 (online)

Also available at
    Permissions and Reprints

Abstract

An undiagnosed pheochromocytoma may result in life-threatening consequences. The diagnosis of pheochromocytoma is based on the overproduction of catecholamines. Highly sensitive biochemical assays are essential to avoid false-negative results. Determinations of 24-h urinary epinephrine and norepinephrine levels are established diagnostic tools. However, they may be falsely negative in patients with a biochemically-silent or periodically-secreting pheochromocytoma. Metanephrines, which are metabolites of catecholamines, have been suggested as an alternative diagnostic tool. Urinary metanephrines are determined by high-pressure liquid chromatography (HPLC) in an increasing number of laboratories, whereas plasma metanephrines measured by HPLC are available in specialised centres only. The different HPLC methods may be cost- and time-intensive. Immunoassays such as radio- or enzyme-immunoassays may be alternative procedures. Measurement of metanephrines instead of catecholamines by either technique improved the diagnostic accuracy for the diagnosis of pheochromocytomas. Determination of plasma free metanephrines demonstrated a higher accuracy than their urinary counterparts. The use of immunoassays may be an alternative to the laborious HPLC, although the method needs to be evaluated in more detail.

Key words

plasma metanephrines - urinary metanephrines - pheochromocytoma - HPLC - immunoassays

References

  • 1 Eisenhofer G, Walther M, Keiser HR, Lenders JW, Friberg P, Pacak K. Plasma metanephrines: a novel and cost-effective test for phaeochromocytoma.  Braz J Med Biol Res. 2000;  33 1157-1169
    Google Scholar
  • 2 Eisenhofer G. Editorial: biochemical diagnosis of phaeochromocytoma – is it time to switch to plasma-free metanephrines?.  J Clin Endocrinol Metab. 2003;  88 550-552
    Google Scholar
  • 3 Roden M. How to detect phaeochromocytomas? – the diagnostic relevance of plasma free metanephrines.  Wien Klin Wochenschr. 2002;  114 246-251
    Google Scholar
  • 4 Sawka AM, Prebtani AP, Thabane L, Gafni A, Levine M, Young Jr WF. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of phaeochromocytoma.  BMC Endocr Disord. 2004;  4 2
    Google Scholar
  • 5 Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW. Plasma metanephrines are markers of phaeochromocytoma produced by catechol-O-methyltransferase within tumors.  J Clin Endocrinol Metab. 1998;  83 2175-2185
    Google Scholar
  • 6 Eisenhofer G, Siegert G, Kotzerke J, Bornstein SR, Pacak K. Current progress and future challenges in the biochemical diagnosis and treatment of phaeochromocytomas and paragangliomas.  Horm Metab Res. 2008;  40 329-337
    Google Scholar
  • 7 Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of phaeochromocytoma: which test is best?.  JAMA. 2002;  287 1427-1434
    Google Scholar
  • 8 Lenders JW, Keiser HR, Goldstein DS, Willemsen JJ, Friberg P, Jacobs MC, Kloppenborg PW, Thien T, Eisenhofer G. Plasma metanephrines in the diagnosis of phaeochromocytoma.  Ann Intern Med. 1995;  123 101-109
    Google Scholar
  • 9 Sawka AM, Jaeschke R, Singh RJ, Young Jr WF. A comparison of biochemical tests for phaeochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.  J Clin Endocrinol Metab. 2003;  88 553-558
    Google Scholar
  • 10 Raber W, Raffesberg W, Bischof M, Scheuba C, Niederle B, Gasic S, Waldhausl W, Roden M. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of phaeochromocytoma.  Arch Intern Med. 2000;  160 2957-2963
    Google Scholar
  • 11 Unger N, Pitt C, Schmidt IL, Walz MK, Schmid KW, Philipp T, Mann K, Petersenn S. Diagnostic value of various biochemical parameters for the diagnosis of phaeochromocytoma in patients with adrenal mass.  Eur J Endocrinol. 2006;  154 409-417
    Google Scholar
  • 12 Gao YC, Lu HK, Luo QY, Chen LB, Ding Y, Zhu RS. Comparison of free plasma metanephrines enzyme immunoassay with (131)I-MIBG scan in diagnosis of phaeochromocytoma.  Clin Exp Med. 2008;  8 87-91
    Google Scholar
  • 13 Lenz T, Zorner J, Kirchmaier C, Pillitteri D, Badenhoop K, Bartel C, Geiger H, Hasselbacher K, Tuschy U, Westermann J, Salewski L. Multicenter study on the diagnostic value of a new RIA for the detection of free plasma metanephrines in the work-up for phaeochromocytoma.  Ann N Y Acad Sci. 2006;  1073 358-373
    Google Scholar
  • 14 Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K. Biochemical diagnosis of phaeochromocytoma: how to distinguish true- from false-positive test results.  J Clin Endocrinol Metab. 2003;  88 2656-2666
    Google Scholar
  • 15 Gardet V, Gatta B, Simonnet G, Tabarin A, Chene G, Ducassou D, Corcuff JB. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of phaeochromocytoma.  J Hypertens. 2001;  19 1029-1035
    Google Scholar
  • 16 Eisenhofer G. Free or total metanephrines for diagnosis of phaeochromocytoma: what is the difference?.  Clin Chem. 2001;  47 988-989
    Google Scholar
  • 17 Eisenhofer G, Huynh TT, Hiroi M, Pacak K. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of phaeochromocytoma.  Rev Endocr Metab Disord. 2001;  2 297-311
    Google Scholar
  • 18 Feldman JM. Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy.  J Clin Pharmacol. 1987;  27 288-292
    Google Scholar
  • 19 Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection.  Clin Chem. 1993;  39 97-103
    Google Scholar
  • 20 Roden M, Raffesberg W, Raber W, Bernroider E, Niederle B, Waldhausl W, Gasic S. Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen.  Clin Chem. 2001;  47 1061-1067
    Google Scholar
  • 21 Wassell J, Reed P, Kane J, Weinkove C. Freedom from drug interference in new immunoassays for urinary catecholamines and metanephrines.  Clin Chem. 1999;  45 2216-2223
    Google Scholar
  • 22 Lenders JW, Willemsen JJ, Eisenhofer G, Ross HA, Pacak K, Timmers HJ, Sweep CG. Is supine rest necessary before blood sampling for plasma metanephrines?.  Clin Chem. 2007;  53 352-354
    Google Scholar
  • 23 Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR. Plasma normetanephrine and metanephrine for detecting phaeochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.  N Engl J Med. 1999;  340 1872-1879
    Google Scholar

Correspondence

S. PetersennMD 

Division of Endocrinology, Medical Center

University of Duisburg-Essen

Hufelandstraße 55

45122 Essen

Germany

Phone: +49/201/723 28 54

Fax: +49/201/723 59 76

Email: stephan.petersenn@uni-due.de

      >